Hepatocyte cholesterol content modulates glucagon receptor signalling. (2022)
Attributed to:
Developmental Clinical Studies - Curing Obesity with the 'Medical Bypass'
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.molmet.2022.101530
PubMed Identifier: 35718339
Publication URI: http://europepmc.org/abstract/MED/35718339
Type: Journal Article/Review
Volume: 63
Parent Publication: Molecular metabolism
ISSN: 2212-8778